Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction
Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Inclusion Criteria:
Exclusion Criteria:
stacia.kraus@alleviantmedical.com612-387-4552
Los Angeles, California 90033, United States
Los Angeles, California 90095, United States
Montreal, Quebec H2X 0C1, Canada
Zrifin, Israel